Go Pro

Brainsway (BWAY) Financials

Brainsway logo
$15.97 -0.54 (-3.27%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$16.56 +0.59 (+3.69%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Brainsway

Annual Income Statements for Brainsway

This table shows Brainsway's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-7.05 -6.48 -10 -5.39 -8.11 -13 -4.20 2.92 7.58
Consolidated Net Income / (Loss)
-7.05 -6.48 -10 -5.39 -6.46 -13 -4.20 2.92 7.58
Net Income / (Loss) Continuing Operations
-7.05 -6.48 -10 -5.39 -8.11 -13 -4.20 2.92 7.58
Total Pre-Tax Income
-6.89 -6.27 -9.91 -5.15 -6.42 -13 -3.95 3.46 7.71
Total Operating Income
-6.61 -5.11 -8.48 -4.83 -9.74 -13 -4.96 1.39 4.32
Total Gross Profit
8.55 13 18 17 23 20 23 31 39
Total Revenue
11 16 23 22 30 27 32 41 52
Operating Revenue
11 16 23 22 30 27 32 41 52
Total Cost of Revenue
2.60 3.59 5.13 5.06 12 7.13 8.31 10 13
Operating Cost of Revenue
2.60 3.59 5.13 5.06 12 7.13 8.31 10 13
Total Operating Expenses
15 18 26 22 28 33 28 29 35
Selling, General & Admin Expense
3.49 3.42 5.30 4.72 5.78 6.85 5.32 5.80 6.53
Marketing Expense
6.33 8.35 13 11 16 18 16 16 19
Research & Development Expense
5.34 6.16 7.88 5.82 6.39 7.68 6.67 7.19 9.60
Total Other Income / (Expense), net
-0.27 -1.16 -1.43 -0.32 1.68 -0.35 1.01 2.07 3.39
Interest Expense
0.27 1.16 1.43 0.32 -1.68 1.47 1.16 1.52 2.21
Interest & Investment Income
- - - - - 1.12 2.17 3.58 5.60
Income Tax Expense
0.17 0.21 0.42 0.24 0.04 0.32 0.25 0.54 0.14
Basic Earnings per Share
($0.48) ($0.39) - ($0.24) - ($0.40) ($0.13) $0.09 $0.20
Weighted Average Basic Shares Outstanding
- - 22.24M 22.25M 32.91M 33.05M 33.24M 37.63M 39.17M
Diluted Earnings per Share
($0.48) ($0.39) - ($0.24) - ($0.40) ($0.13) $0.05 $0.18
Weighted Average Diluted Shares Outstanding
- - 22.24M 22.25M 32.91M 33.05M 33.24M 37.63M 39.17M
Weighted Average Basic & Diluted Shares Outstanding
- - 22.24M 22.25M 32.91M 33.05M 33.24M 37.63M 39.17M

Quarterly Income Statements for Brainsway

No quarterly income statements for Brainsway are available.


Annual Cash Flow Statements for Brainsway

This table details how cash moves in and out of Brainsway's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
5.34 -5.54 -16 -6.11 -3.45 31 -37 59 15
Net Cash From Operating Activities
-5.29 -2.54 -9.52 -3.64 -1.21 -8.24 -29 19 17
Net Cash From Continuing Operating Activities
-5.29 -2.54 -9.52 -3.64 -1.21 -8.24 -29 19 17
Net Income / (Loss) Continuing Operations
-7.05 -6.48 -10 -5.39 -6.46 0.00 1.01 2.07 7.58
Consolidated Net Income / (Loss)
-7.05 -6.48 -10 -5.39 -6.46 - 1.01 2.07 7.58
Depreciation Expense
1.07 1.23 0.55 0.44 0.56 1.53 1.34 1.77 0.67
Non-Cash Adjustments To Reconcile Net Income
-0.34 2.89 -0.30 0.99 2.65 -11 -32 10 -0.26
Changes in Operating Assets and Liabilities, net
1.03 -0.18 0.56 0.32 2.04 1.00 1.30 4.71 9.25
Net Cash From Investing Activities
-0.45 -2.02 -3.31 -2.47 -2.24 1.94 -2.39 -3.79 -2.34
Net Cash From Continuing Investing Activities
-0.45 -2.02 -3.31 -2.47 -2.24 1.94 -2.39 -3.79 -2.34
Sale of Property, Plant & Equipment
- - - -2.47 -2.24 1.94 -2.39 -3.79 -2.34
Net Cash From Financing Activities
11 0.00 -3.00 0.00 0.00 40 0.00 51 0.00
Net Cash From Continuing Financing Activities
11 0.00 -3.00 0.00 0.00 40 0.00 51 0.00
Other Financing Activities, net
- - - - - - - - 0.00
Cash Interest Received
0.01 0.04 0.18 0.06 0.02 1.04 1.71 2.92 3.40

Quarterly Cash Flow Statements for Brainsway

No quarterly cash flow statements for Brainsway are available.


Annual Balance Sheets for Brainsway

This table presents Brainsway's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
24 39 34 76 64 63 94 113
Total Current Assets
13 29 24 65 58 55 80 84
Cash & Equivalents
8.97 22 17 17 48 11 69 68
Restricted Cash
- - - - 0.27 0.27 0.27 0.25
Accounts Receivable
4.41 6.93 5.58 6.33 4.84 3.78 4.60 4.11
Inventories, net
- - - 0.00 3.84 3.72 4.43 6.52
Other Current Assets
- - 1.53 1.77 1.56 1.71 1.03 3.81
Plant, Property, & Equipment, net
7.49 4.17 0.71 1.06 1.01 0.39 0.75 0.79
Plant, Property & Equipment, gross
7.49 4.17 0.71 1.06 1.01 0.39 0.75 0.79
Total Noncurrent Assets
2.60 5.88 9.22 50 5.38 43 14 30
Noncurrent Note & Lease Receivables
- 5.49 5.20 3.81 3.12 3.70 3.96 4.86
Other Noncurrent Operating Assets
2.60 0.39 4.03 46 2.26 39 9.94 25
Total Liabilities & Shareholders' Equity
24 39 34 76 64 63 94 113
Total Liabilities
20 14 14 18 19 21 32 40
Total Current Liabilities
7.04 6.00 6.09 8.09 7.08 8.75 14 21
Accounts Payable
5.70 4.70 4.55 5.89 5.61 6.02 8.80 9.19
Current Deferred Revenue
1.33 1.31 1.54 2.20 1.48 2.50 4.43 11
Other Current Liabilities
- - - - - 0.23 0.82 1.08
Total Noncurrent Liabilities
13 8.43 8.28 10 12 13 18 19
Capital Lease Obligations
- - - - - 0.24 4.80 5.74
Noncurrent Deferred Revenue
1.11 2.35 2.05 3.42 4.92 5.31 3.63 6.76
Other Noncurrent Operating Liabilities
8.89 6.08 6.23 6.90 7.07 7.09 9.53 6.71
Total Equity & Noncontrolling Interests
3.60 24 20 57 45 42 62 73
Total Preferred & Common Equity
3.60 24 20 57 45 42 62 73
Total Common Equity
3.60 24 20 57 45 42 62 73
Common Stock
0.17 0.23 0.23 0.36 0.36 0.37 0.41 0.43
Retained Earnings
-62 -72 -77 -84 -97 -101 -98 -91
Accumulated Other Comprehensive Income / (Loss)
- - -2.19 -2.19 -2.19 -2.19 -2.19 -2.19
Other Equity Adjustments
65 96 99 143 144 145 162 166

Quarterly Balance Sheets for Brainsway

No quarterly balance sheets for Brainsway are available.


Annual Metrics And Ratios for Brainsway

This table displays calculated financial ratios and metrics derived from Brainsway's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 22,236,368.00 22,250,534.00 32,911,134.00 33,053,323.00 33,242,189.00 - 39,165,806.00
DEI Adjusted Shares Outstanding
0.00 0.00 22,236,368.00 22,250,534.00 32,911,134.00 33,053,323.00 66,484,378.00 - 39,165,806.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -0.46 -0.24 -0.25 -0.40 -0.06 - 0.19
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 47.12% 40.89% -4.52% 35.61% -9.14% 16.96% 29.04% 27.33%
EBITDA Growth
0.00% 29.84% -103.96% 44.60% -109.13% -21.41% 67.51% 187.30% 57.75%
EBIT Growth
0.00% 22.64% -65.74% 43.03% -101.76% -30.18% 60.90% 128.05% 210.78%
NOPAT Growth
0.00% 22.64% -65.74% 43.03% -101.76% -30.18% 60.90% 133.84% 261.58%
Net Income Growth
0.00% 8.15% -59.41% 47.86% -20.00% -106.58% 68.56% 169.60% 159.33%
EPS Growth
0.00% 18.75% 0.00% 0.00% 0.00% 0.00% 68.56% 138.46% 159.33%
Operating Cash Flow Growth
0.00% 52.10% -275.35% 61.79% 66.73% -580.99% -248.03% 143.86% -7.25%
Free Cash Flow Firm Growth
0.00% 0.00% -959.74% 68.17% -1,170.24% 176.27% -208.75% 193.92% -126.54%
Invested Capital Growth
0.00% 0.00% 200.24% 4.99% 1,411.56% -106.08% 1,363.91% -108.07% 537.63%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - -
Gross Margin
76.72% 78.11% 77.80% 77.07% 77.09% 73.77% 73.86% 74.56% 75.42%
EBITDA Margin
-49.70% -23.70% -34.31% -19.91% -30.70% -41.02% -11.40% 7.71% 9.55%
Operating Margin
-59.32% -31.19% -36.69% -21.89% -32.57% -46.67% -15.60% 3.39% 8.28%
EBIT Margin
-59.32% -31.19% -36.69% -21.89% -32.57% -46.67% -15.60% 3.39% 8.28%
Profit (Net Income) Margin
-63.29% -39.51% -44.71% -24.41% -21.60% -49.12% -13.20% 7.12% 14.50%
Tax Burden Percent
102.45% 103.33% 104.26% 104.60% 100.67% 102.42% 106.36% 84.45% 98.25%
Interest Burden Percent
104.14% 122.60% 116.87% 106.61% 65.88% 102.77% 79.57% 248.67% 178.35%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 15.55% 1.75%
Return on Invested Capital (ROIC)
0.00% 0.00% -197,773.33% -129.54% -31.66% -46.79% -24.30% 8.24% 100.52%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -197,741.73% -119.16% -33.78% -32.98% -21.81% 3.60% 95.28%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 197,699.07% 104.98% 14.87% 20.80% 14.65% -2.61% -89.33%
Return on Equity (ROE)
0.00% -180.22% -74.26% -24.56% -16.79% -25.99% -9.65% 5.62% 11.18%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -432.80% -134.41% -206.84% 0.00% -119.10% 0.00% -84.08%
Operating Return on Assets (OROA)
0.00% -21.67% -27.19% -13.28% -17.76% -18.09% -7.78% 1.77% 4.17%
Return on Assets (ROA)
0.00% -27.45% -33.14% -14.80% -11.78% -19.04% -6.59% 3.71% 7.30%
Return on Common Equity (ROCE)
0.00% -180.22% -74.26% -24.56% -16.79% -25.99% -9.65% 5.62% 11.18%
Return on Equity Simple (ROE_SIMPLE)
0.00% -180.22% -42.64% -27.43% -11.27% -29.41% 0.00% 4.69% 0.00%
Net Operating Profit after Tax (NOPAT)
-4.63 -3.58 -5.93 -3.38 -6.82 -8.88 -3.47 1.17 4.25
NOPAT Margin
-41.52% -21.83% -25.68% -15.33% -22.80% -32.67% -10.92% 2.86% 8.13%
Net Nonoperating Expense Percent (NNEP)
0.00% -94.51% -31.61% -10.38% 2.11% -13.80% -2.49% 4.63% 5.24%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -19.56% -8.30% 1.75% 5.38%
Cost of Revenue to Revenue
23.28% 21.89% 22.20% 22.93% 38.77% 26.23% 26.14% 25.44% 24.58%
SG&A Expenses to Revenue
31.29% 20.86% 22.96% 21.41% 19.34% 25.22% 16.72% 14.13% 12.50%
R&D to Revenue
47.94% 37.54% 34.09% 26.40% 21.37% 28.25% 20.97% 17.53% 18.39%
Operating Expenses to Revenue
136.03% 109.30% 114.49% 98.96% 93.80% 120.44% 89.46% 71.17% 67.14%
Earnings before Interest and Taxes (EBIT)
-6.61 -5.11 -8.48 -4.83 -9.74 -13 -4.96 1.39 4.32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-5.54 -3.89 -7.93 -4.39 -9.18 -11 -3.62 3.16 4.99
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 7.65 1.01 4.27 1.49 0.90 2.58 2.52 4.89
Price to Tangible Book Value (P/TBV)
0.00 7.65 1.01 4.27 1.49 0.90 2.58 2.52 4.89
Price to Revenue (P/Rev)
2.47 1.68 1.06 3.80 2.86 1.50 3.37 3.82 6.85
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 53.66 47.24
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.86% 2.12%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.06 25.02 1.70 0.00 3.11 0.00 26.99
Enterprise Value to Revenue (EV/Rev)
0.00 1.30 0.12 3.03 2.30 0.00 3.04 2.24 5.66
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 29.07 59.27
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 66.08 68.38
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 78.25 69.60
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.82 17.15
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.65 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 0.79 0.00 0.00 0.00 0.00 0.01 0.08 0.08
Long-Term Debt to Equity
0.00 0.79 0.00 0.00 0.00 0.00 0.01 0.08 0.08
Financial Leverage
0.00 -1.71 -1.00 -0.88 -0.44 -0.63 -0.67 -0.73 -0.94
Leverage Ratio
0.00 6.57 2.24 1.66 1.43 1.36 1.47 1.51 1.53
Compound Leverage Factor
0.00 8.05 2.62 1.77 0.94 1.40 1.17 3.76 2.73
Debt to Total Capital
0.00% 44.07% 0.00% 0.00% 0.00% 0.00% 0.57% 7.15% 7.28%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 44.07% 0.00% 0.00% 0.00% 0.00% 0.57% 7.15% 7.28%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 55.93% 100.00% 100.00% 100.00% 100.00% 99.43% 92.85% 92.72%
Debt to EBITDA
0.00 -0.73 0.00 0.00 0.00 0.00 -0.07 1.52 1.15
Net Debt to EBITDA
0.00 1.58 0.00 0.00 0.00 0.00 2.91 -20.50 -12.47
Long-Term Debt to EBITDA
0.00 -0.73 0.00 0.00 0.00 0.00 -0.07 1.52 1.15
Debt to NOPAT
0.00 -0.79 0.00 0.00 0.00 0.00 -0.07 4.09 1.35
Net Debt to NOPAT
0.00 1.71 0.00 0.00 0.00 0.00 3.04 -55.18 -14.65
Long-Term Debt to NOPAT
0.00 -0.79 0.00 0.00 0.00 0.00 -0.07 4.09 1.35
Altman Z-Score
0.00 -2.52 -1.00 1.14 2.12 -0.11 1.89 2.80 5.50
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 1.92 4.80 3.99 8.09 8.20 6.34 5.67 4.03
Quick Ratio
0.00 1.90 4.76 3.70 2.87 7.40 1.63 5.26 3.45
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -1.04 -11 -3.51 -45 34 -37 35 -9.21
Operating Cash Flow to CapEx
-537.46% -128.60% -287.50% -147.25% -54.07% 0.00% -1,201.42% 355.19% 736.58%
Free Cash Flow to Firm to Interest Expense
0.00 -0.90 -7.71 -10.99 0.00 23.15 -31.91 22.89 -4.17
Operating Cash Flow to Interest Expense
-19.32 -2.19 -6.66 -11.40 0.00 -5.61 -24.77 8.89 7.80
Operating Cash Flow Less CapEx to Interest Expense
-22.92 -3.90 -8.97 -19.14 0.00 -4.29 -26.83 6.39 6.74
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.69 0.74 0.61 0.55 0.39 0.50 0.52 0.50
Accounts Receivable Turnover
0.00 3.72 4.07 3.52 5.02 4.86 7.37 9.79 12.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 2.20 2.56 2.35
Fixed Asset Turnover
0.00 2.19 3.96 9.04 33.89 26.35 45.50 71.89 67.82
Accounts Payable Turnover
0.00 0.63 0.99 1.09 2.22 1.24 1.43 1.41 1.43
Days Sales Outstanding (DSO)
0.00 98.15 89.61 103.56 72.69 75.05 49.52 37.27 30.43
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 165.94 142.41 155.63
Days Payable Outstanding (DPO)
0.00 579.89 370.09 333.72 164.34 294.42 255.34 259.05 255.65
Cash Conversion Cycle (CCC)
0.00 -481.75 -280.48 -230.16 -91.65 -219.37 -39.89 -79.37 -69.59
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 -2.54 2.55 2.67 40 -2.46 31 -2.50 11
Invested Capital Turnover
0.00 -12.91 7,700.33 8.45 1.39 1.43 2.22 2.88 12.36
Increase / (Decrease) in Invested Capital
0.00 -2.54 5.09 0.13 38 -43 33 -34 13
Enterprise Value (EV)
0.00 21 2.70 67 69 -7.21 97 92 296
Market Capitalization
28 28 24 84 86 41 107 157 358
Book Value per Share
$0.00 $1.44 $1.09 $0.88 $2.58 $1.38 $1.26 $1.87 $1.94
Tangible Book Value per Share
$0.00 $1.44 $1.09 $0.88 $2.58 $1.38 $1.26 $1.87 $1.94
Total Capital
0.00 6.43 24 20 57 45 42 67 79
Total Debt
0.00 2.83 0.00 0.00 0.00 0.00 0.24 4.80 5.74
Total Long-Term Debt
0.00 2.83 0.00 0.00 0.00 0.00 0.24 4.80 5.74
Net Debt
0.00 -6.14 -22 -17 -17 -48 -11 -65 -62
Capital Expenditures (CapEx)
0.99 1.97 3.31 2.47 2.24 -1.94 2.39 3.79 2.34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -2.53 1.15 1.24 40 3.15 36 -4.00 -4.94
Debt-free Net Working Capital (DFNWC)
0.00 6.44 23 18 57 51 47 66 63
Net Working Capital (NWC)
0.00 6.44 23 18 57 51 47 66 63
Net Nonoperating Expense (NNE)
2.43 2.90 4.39 2.00 -0.36 4.47 0.73 -1.75 -3.33
Net Nonoperating Obligations (NNO)
0.00 -6.14 -22 -17 -17 -48 -11 -65 -62
Total Depreciation and Amortization (D&A)
1.07 1.23 0.55 0.44 0.56 1.53 1.34 1.77 0.67
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -15.40% 4.98% 5.64% 135.19% 11.60% 113.01% -9.75% -9.46%
Debt-free Net Working Capital to Revenue
0.00% 39.29% 98.81% 82.54% 191.76% 187.68% 146.96% 159.98% 120.65%
Net Working Capital to Revenue
0.00% 39.29% 98.81% 82.54% 191.76% 187.68% 146.96% 159.98% 120.65%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.50) ($0.24) $0.00 ($0.40) $0.00 $0.09 $0.20
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 22.24M 22.25M 32.91M 33.05M 66.48M 37.63M 39.17M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.50) ($0.24) $0.00 ($0.40) $0.00 $0.05 $0.18
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 22.24M 22.25M 32.91M 33.05M 66.48M 37.63M 39.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($0.50) ($0.24) $0.00 ($0.40) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 22.24M 22.25M 32.91M 33.05M 66.48M 37.63M 39.17M
Normalized Net Operating Profit after Tax (NOPAT)
-4.63 -3.58 -5.93 -3.38 -6.82 -8.88 -3.47 1.17 4.25
Normalized NOPAT Margin
-41.52% -21.83% -25.68% -15.33% -22.80% -32.67% -10.92% 2.86% 8.13%
Pre Tax Income Margin
-61.78% -38.24% -42.88% -23.34% -21.46% -47.96% -12.41% 8.43% 14.76%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
-24.13 -4.42 -5.93 -15.14 0.00 -8.64 -4.28 0.92 1.96
NOPAT to Interest Expense
-16.89 -3.10 -4.15 -10.60 0.00 -6.05 -3.00 0.77 1.92
EBIT Less CapEx to Interest Expense
-27.72 -6.13 -8.24 -22.88 0.00 -7.32 -6.34 -1.59 0.90
NOPAT Less CapEx to Interest Expense
-20.48 -4.80 -6.46 -18.34 0.00 -4.73 -5.06 -1.73 0.86
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Brainsway

No quarterly metrics and ratios for Brainsway are available.



Financials Breakdown Chart

Brainsway Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Brainsway's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Brainsway's net income appears to be on a downward trend, with a most recent value of $7.58 million in 2025, falling from -$7.05 million in 2017. The previous period was $2.92 million in 2024. View Brainsway's forecast to see where analysts expect Brainsway to go next.

Brainsway's total operating income in 2025 was $4.32 million, based on the following breakdown:
  • Total Gross Profit: $39.39 million
  • Total Operating Expenses: $35.06 million

Over the last 8 years, Brainsway's total revenue changed from $11.15 million in 2017 to $52.23 million in 2025, a change of 368.6%.

Brainsway's total liabilities were at $40.03 million at the end of 2025, a 25.1% increase from 2024, and a 101.5% increase since 2018.

In the past 7 years, Brainsway's cash and equivalents has ranged from $8.97 million in 2018 to $69.35 million in 2024, and is currently $67.70 million as of their latest financial filing in 2025.

Over the last 8 years, Brainsway's book value per share changed from 0.00 in 2017 to 1.94 in 2025, a change of 194.5%.



Financial statements for NASDAQ:BWAY last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners